| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 11/13/2013 | CN102229562B Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 11/13/2013 | CN102105451B Glucokinase activators |
| 11/13/2013 | CN102100761B Plant extract composition for preventing and treating lipidmetabolic disorder and preparation method thereof |
| 11/13/2013 | CN101961424B Pu-erh tea extract and preparation thereof |
| 11/13/2013 | CN101961422B Extractive of Pu'er tea and preparation method thereof |
| 11/12/2013 | US8580959 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 11/12/2013 | US8580811 Androgen receptor modulator methods |
| 11/12/2013 | US8580796 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 11/12/2013 | US8580780 6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist |
| 11/12/2013 | US8580743 Modified galectin 9 proteins and methods of treatment using them |
| 11/12/2013 | US8580733 Site-specific monoconjugated insulinotropic GLP-1 peptides |
| 11/12/2013 | US8580563 Placental stem cells |
| 11/12/2013 | CA2584709C Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 11/12/2013 | CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 11/12/2013 | CA2448379C Calorically dense liquid oral supplement |
| 11/12/2013 | CA2448022C Compositions for protein delivery via the pulmonary route |
| 11/07/2013 | WO2013166448A1 Stable formulations containing anti-pcsk9 antibodies |
| 11/07/2013 | WO2013165921A2 Therapeutic use of chardonnay seed products |
| 11/07/2013 | WO2013165800A1 2α-METHYL-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 (2AMD) OR 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 (2MD) SUPPORT SURVIVAL AND FUNCTION OF TRANSPLANTED ISLET CELLS IN TYPE 1 DIABETES |
| 11/07/2013 | WO2013165776A1 Anti-obesity properties of pterostilbene |
| 11/07/2013 | WO2013164838A1 Heterocyclic compounds and their use for treatment of diabetes, obesity or related disorders |
| 11/07/2013 | WO2013164730A1 Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin- 2 -amine compounds as inhibitors of app, bace1 and bace 2. |
| 11/07/2013 | WO2013164292A1 Indanyloxydihydrobenzofuranylacetic acids |
| 11/07/2013 | WO2013163744A1 Nutrition formulation and product produced therefrom comprising whey protein. |
| 11/07/2013 | US20130296441 Anti-Obesity Properties of Pterostilbene |
| 11/07/2013 | US20130295009 Method of treating inflammation |
| 11/07/2013 | CA2839781A1 Nutrition formulation and product produced therefrom |
| 11/06/2013 | EP2659904A1 Use of Hsp70 as a regulator of enzymatic activity |
| 11/06/2013 | EP2658567A1 Methods of modifying insulin signaling using biliverdin reductase (bvr) and bvr derived peptides |
| 11/06/2013 | EP2658550A1 Agonists of toll like receptor for treating cardiovasuclar disease and obesity |
| 11/06/2013 | EP2658533A2 Combination of components for the prevention and treatment of frailty |
| 11/06/2013 | CN103384661A Mineralocorticoid receptor antagonists |
| 11/06/2013 | CN103384659A Thioamide compound, method for producing thioamide compound, method for producing [(4r,6r)-6-aminoethyl-1,3-dioxane-4-yl]acetate derivative, and method for producing atorvastatin |
| 11/06/2013 | CN103384527A Ppar活化剂 Ppar activator |
| 11/06/2013 | CN103384520A Combination of components for the prevention and treatment of frailty |
| 11/06/2013 | CN103382222A Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 11/06/2013 | CN103382206A Quinoline or quinazoline derivative, its preparation method and application in medicines |
| 11/06/2013 | CN103382201A Heteroaryl derivatives as cftr modulators |
| 11/06/2013 | CN103382177A Roflumilast N-oxide polymorphs and their preparation methods and pharmaceutical composition |
| 11/06/2013 | CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments |
| 11/06/2013 | CN103382174A Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 11/06/2013 | CN103381209A Hawthorne leaf total-flavones sustained-release preparation and preparation method thereof |
| 11/06/2013 | CN103381200A White mulberry root-bark total alkaloid extract and preparation and application thereof |
| 11/06/2013 | CN103381195A Fat emulsion injection and preparation method thereof |
| 11/06/2013 | CN103381173A Application of Kudingcha saponin D in preparation of pharmaceuticals |
| 11/06/2013 | CN103381161A Application of compound SC-51089 to prepare medicaments for treating diabetes and complications |
| 11/06/2013 | CN103381152A Application of myricetin used as cathepsin K inhibitor |
| 11/06/2013 | CN103381150A Pharmaceutical composition and application thereof |
| 11/06/2013 | CN103381138A Statin oral self-microemulsifying release preparation and preparation method thereof |
| 11/06/2013 | CN103381136A Edible cosmetics and preparation method thereof |
| 11/06/2013 | CN102952661B Method for preparing green tea health-care wine |
| 11/06/2013 | CN102764262B Application of oleanolic acid and retinoic acid pharmaceutical composition in medicament for treating insulin resistance and diabetes |
| 11/06/2013 | CN102670724B Composition with effect of treating diabetes and preparation method and application thereof |
| 11/06/2013 | CN102631662B Composition with functions of protecting liver and relieving fatigue and preparation method of composition |
| 11/06/2013 | CN102599501B Healthcare Hongyang capsule or tablet product for lowering lipid and protecting liver |
| 11/06/2013 | CN102585015B Fusion protein containing glicetin-1 as well as preparation method and application |
| 11/06/2013 | CN102580030B External traditional Chinese medicine composition having effect of reducing blood sugar, preparation prepared from the external traditional Chinese medicine composition, and their preparation method |
| 11/06/2013 | CN102552884B Weight loss secret recipe of Zhuang medicine |
| 11/06/2013 | CN102552289B Composition for treating diabetes and preparation method |
| 11/06/2013 | CN102526672B Traditional Chinese medicine composition, applications and preparation method |
| 11/06/2013 | CN102370707B Method for preparing mulberry leaf and/or mulberry twig extract, obtained product thereof and application thereof |
| 11/06/2013 | CN102219670B Linear chain polyketone compounds and application thereof |
| 11/06/2013 | CN102212093B Flavonoid glycoside compounds, method for preparing same and application |
| 11/06/2013 | CN102196810B Pharmaceutical composition improved in absorption through intestinal tract |
| 11/06/2013 | CN102006869B Treatment of energy utilization disease |
| 11/06/2013 | CN101991163B Oligosaccharide oat beverage capable of treating hyperlipoidemia and hyperglycemia and improving gastrointestinal tract |
| 11/06/2013 | CN101982458B 3-amino-3-arylpropionic acid and preparation method thereof |
| 11/06/2013 | CN101965337B Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 11/06/2013 | CN101926872B Chinese medicinal detoxifying myo-regeneration paste for treating diabetic foot ulcer and preparation method thereof |
| 11/06/2013 | CN101918376B 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 11/06/2013 | CN101855241B Monoclonal antibodies against ANGPTL3 |
| 11/06/2013 | CN101757057B Whiteflower leadword root chewable tablet |
| 11/06/2013 | CN101574424B Application of medicine combination in preparing medicament with function of protecting pancreatic island |
| 11/06/2013 | CN101484391B Method for activating and stabilizing dissolved hydrogen in water |
| 11/06/2013 | CN101448822B Substituted pyrazolopyrimidines |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/06/2013 | CN101189337B Ghrelin binding nucleic acids |
| 11/05/2013 | US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| 11/05/2013 | US8575204 Nicotinamide derivates useful as P38 inhibitors |
| 11/05/2013 | US8575186 Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
| 11/05/2013 | US8575167 Spiro compounds having stearoyl-CoA desaturase action |
| 11/05/2013 | US8575161 Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
| 11/05/2013 | US8575149 5HT2C receptor modulators |
| 11/05/2013 | US8575148 Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers |
| 11/05/2013 | US8575097 Exendin variant and conjugate thereof |
| 11/05/2013 | US8575091 Amylin analogues and pharmaceutical compositions thereof |
| 11/05/2013 | US8575090 Amylin analogues and pharmaceutical compositions thereof |
| 11/05/2013 | US8574909 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter gene |
| 11/05/2013 | US8574586 KDR peptides and vaccines comprising the same |
| 11/05/2013 | US8574585 KDR peptides and vaccines comprising the same |
| 11/05/2013 | CA2364417C Peroral gene therapy of diabetes and obesity |
| 10/31/2013 | WO2013163508A1 Tetrahydropyran dgat1 inhibitors |
| 10/31/2013 | WO2013162484A1 A combination of fig (ficus carica) fruit extract and olive (olea europaea) leaf extract |
| 10/31/2013 | WO2013162298A1 Novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient |
| 10/31/2013 | WO2013162050A1 Lactoferrin fusion protein and method for producing same |
| 10/31/2013 | WO2013161821A1 Cgrp responsiveness promoter |
| 10/31/2013 | WO2013161816A1 Amine compound and use thereof for medical purposes |
| 10/31/2013 | WO2013161378A1 Method for producing composition containing fucoxanthin |
| 10/31/2013 | WO2013161359A1 Enteral environment-improving agent |
| 10/31/2013 | WO2013160873A1 Cyclic bridgehead ether dgat1 inhibitors |